We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




One-Third of Breast Cancer Cases Treated Unnecessarily

By HospiMedica International staff writers
Posted on 26 Jan 2017
Print article
A new study suggests that one in three women with breast cancer detected by a mammogram may be treated unnecessarily.

Researchers at the Nordic Cochrane Centre, the University of Oslo, and the Norwegian Institute of Public Health conducted a cohort study to assess the association between biennial mammography screening and the size of detected tumors in women aged 35 to 84 years, measuring trends in the incidence of advanced (>20 mm) and non-advanced (≤20 mm) breast cancer tumors in both screened and non-screened women.

Two approaches were used to estimate the amount of over-diagnosis. The first compared the incidence of advance and non-advanced tumors among women aged 50-84 years in screening and non-screening areas; the second compared the incidence for non-advanced tumors among women aged 35-49, 50-69, and 70-84 years in screening and non-screening areas. The researchers assumed that if screenings work as intended, the number of small, curable breast tumors should increase, reducing the number of large cancers by about the same amount.

The results revealed that screening was not associated with lower incidence of advanced tumors. The first approach found 271 invasive breast cancer tumors and 179 ductal carcinoma in situ (DCIS) lesions over-diagnosed in 2010, an over-diagnosis rate of 24.4% (including DCIS) and 14.7% (excluding DCIS). The second approach, which accounted for regional differences in women younger than the screening age, found 711 invasive tumors and 180 cases of DCIS over-diagnosed in 2010, an over-diagnosis rate of 48.3% (including DCIS) and 38.6% (excluding DCIS). The study was published on January 10, 2017, in Annals of Internal Medicine.

“Breast cancer screening was not associated with a reduction in the incidence of advanced cancer. It is likely that one in every three invasive tumors and cases of DCIS diagnosed in women offered screening represent over-diagnosis,” concluded study coauthor Karsten Jorgensen, PhD, of the Nordic Cochrane Center, and colleagues. “Although mammograms in Denmark detected a lot more breast cancers, these were mostly small, early-stage tumors. The number of advanced cancers did not fall.”

DCIS is the most common type of non-invasive breast cancer, in which the abnormal cells are contained inside the milk ducts. If DCIS is not treated, it may eventually develop into invasive breast cancer, which can spread outside the ducts into the breast tissue and then possibly to other parts of the body. Since DCIS cannot usually be felt as a breast lump or other breast change, most cases are diagnosed following routine screening with mammograms or ultrasound, appearing as micro-calcifications.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Shoulder Positioner
HE-JB2
New
Phlebotomy Chair
CHE03/BH

Print article

Channels

Critical Care

view channel
Image: The schematic illustration of the synthesis process of Qx-D (A) and the rat model of femoral infectious bone defect (B) (Photo courtesy of Fu-Jian Xu Lab/BUCT)

Groundbreaking Dual-Functional Bone Regeneration Scaffold Shows Promise for Infected Bone Defect Treatment

Managing infected bone defects (IBDs) has long been a significant challenge in orthopedic medicine. However, recent advancements in biomaterials have led to the development of innovative bone regeneration... Read more

Surgical Techniques

view channel
Image: The iReach Omnia with 90° articulation (Photo courtesy of Genesis Medtech)

World's First 90° Articulation Powered Stapler Revolutionizes Surgical Precision

Colorectal cancer ranks among the top three cancers globally, impacting millions of individuals annually. While surgical resection remains the primary treatment for low rectal cancer, surgeons encounter... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.